Cerivastatin

被引:38
作者
McClellan, KJ [1 ]
Wiseman, LR [1 ]
McTavish, D [1 ]
机构
[1] Adis Int Ltd, Auckland 10, New Zealand
关键词
D O I
10.2165/00003495-199855030-00009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cerivastatin is a synthetic HMG-CoA reductase inhibitor with high liver selectivity, which lowers plasma cholesterol levels by inhibiting endogenous cholesterol synthesis. In vitro, the affinity of cerivastatin for HMG-CoA reductase was higher than that of lovastatin, simvastatin and pravastatin. This higher enzyme affinity was reflected in vivo, with a lower ED50 (dose causing 50% inhibition) for cerivastatin in rats and beagle dogs compared with lovastatin, Cerivastatin 0.2 mg/day significantly reduced low density lipoprotein (LDL)-cholesterol, total cholesterol and triglyceride levels, and increased high density lipoprotein (HDL)-cholesterol levels, in patients with type IIa hypercholesterolaemia. Available data indicate that cerivastatin has a tolerability profile similar to that of other HMG-CoA reductase inhibitors. No drug interactions were observed when cerivastatin was coadministered with digoxin, warfarin, cimetidine or the antacid magnesium/aluminium hydroxide.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 31 条
  • [21] OCHMANN K, 1997, 2 C EUR ASS CLIN PHA
  • [22] PEDERSEN TR, 1994, LANCET, V344, P1383
  • [23] RITTER W, 1993, CLIN PHARMACOL THER, V53, P210
  • [24] The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
    Sacks, FM
    Pfeffer, MA
    Moye, LA
    Rouleau, JL
    Rutherford, JD
    Cole, TG
    Brown, L
    Warnica, JW
    Arnold, JMO
    Wun, CC
    Davis, BR
    Braunwald, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) : 1001 - 1009
  • [25] NO PHARMACOKINETIC OR PHARMACODYNAMIC INTERACTION BETWEEN RIVASTATIN AND WARFARIN
    SCHALL, R
    MULLER, FO
    HUNDT, HKL
    RITTER, W
    DUURSEMA, L
    GROENEWOUD, G
    MIDDLE, MV
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (03) : 306 - 313
  • [26] PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
    SHEPHERD, J
    COBBE, SM
    FORD, I
    ISLES, CG
    LORIMER, AR
    MACFARLANE, PW
    MCKILLOP, JH
    PACKARD, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) : 1301 - 1307
  • [27] Stein, 1997, J Cardiovasc Pharmacol Ther, V2, P7, DOI 10.1177/107424849700200102
  • [28] STEIN EA, 1997, ATHEROSCLEROSIS SUPP, V130, pS33
  • [29] STEINKE W, 1996, YAKURI TO CHIRYO S9, V24, P1217
  • [30] Vormfelde SV, 1997, ATHEROSCLEROSIS, V130, P127